KDM1A and cancer: In our in vitro studies, Nuc01 displayed potent inhibitory activity against the LSD1 enzyme, with an IC50 of 0.53 μM (Figure 4), and significantly inhibited the proliferation of the human cancer cell line MDA-MB-231, with an IC50 of 1.13 μM (Figure 5).